No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS
Alan Gill, Joshua Kidd, Fernando Vieira et al. · 2009
Read No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS by Alan Gill, Joshua Kidd, Fernando Vieira et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006489.txt.
Description
Alan Gill, Joshua Kidd, Fernando Vieira, and colleagues reported a negative drug trial in PLOS ONE in 2009. In animal models of human disease, a positive control therapy matters. If a treatment works in both the model and the human disease, it validates the model. Lithium was a candidate for such a test in a sibling-matched, gender-balanced, investigator-blinded trial.
Their title states the result plainly: no benefit from chronic lithium dosing in the trial. Negative results are vital, even when disappointing. They stop other teams from wasting effort on a dead end. They also question how well the animal model matches the human condition it was meant to mirror.
Catalog record
| CREATOR | Alan Gill, Joshua Kidd, Fernando Vieira et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006489